solomo.ai

Emami Ltd (EMAMILTD) — shareholding pattern, promoter holding, financials and share price

About Emami Ltd (EMAMILTD)

Emami Ltd operates in the Personal Care industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as EMAMILTD and on the BSE under scrip code 531162. Its ISIN is INE548C01032.

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)

Emami Limited is a leading FMCG company in India, specializing in personal care and healthcare products, with prominent brands like Navratna, BoroPlus, and Zandu in its portfolio.

In Q3FY26, Emami achieved strong performance with consolidated net sales of ₹1,147 crore, growing by 11%, driven by a robust 9% volume growth in its domestic market and 9% growth in international business.

Listed peers in Personal Care: Procter & Gamble Hygiene and Health Care Ltd, Cupid Ltd, Gillette India Ltd, Honasa Consumer Ltd, Bajaj Consumer Care Ltd, Anondita Medicare Ltd.

Valuation & Returns

10 Jul 2026

At ₹423 a share on 10 Jul 2026, Emami Ltd (EMAMILTD) was valued at a price-to-earnings ratio of 23.82x against an industry P/E of 46.1x and a price-to-book of 6.85x on a book value of ₹61.74 per share as of Mar 2025. Solomo computes return on equity of 28.77% and return on capital employed of 30.78% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
23.82x
Industry P/E
46.1x
P/B
6.85x
EPS (TTM)
₹17.76
Book value / share
₹61.74
ROE
28.77%
ROCE
30.78%
ROA
21.94%
Debt / equity
0.03x
Dividend yield
2.36%
EBITDA margin
27.37%
52-week range
₹376.05 – ₹634.65

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Emami Ltd (EMAMILTD) reported revenue of ₹3,780 crore, net profit of ₹775 crore and earnings per share of ₹17.76. That compares with revenue of ₹3,809 crore and net profit of ₹803 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹925 crore and net profit ₹143 crore (consolidated).

Consolidated annual results for Emami Ltd (EMAMILTD), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)3,1923,4063,5783,8093,780
Net profit (₹ cr)837627724803775
EPS (₹)19.0214.516.5818.4817.76
Compound annual growth for Emami Ltd (EMAMILTD). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth4.03%5.50%2.90%6.46%
Profit growth11.14%24.34%0.33%10.85%
Stock price CAGR-3%-6%-1%-31%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 54.84% of Emami Ltd (EMAMILTD) (unchanged from the previous quarter), foreign institutional investors (FII) hold 7.87% and domestic institutional investors (DII) hold 27.01%. Promoters have pledged 16.2% of their holding. Market capitalisation was ₹18,464 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: NIPPON LIFE INDIA TRUSTEE LTD.- A/C NIPPON INDIA NIFTY 500 QUALITY 50 INDEX FUND 6.64%, DSP AGGRESSIVE HYBRID FUND 4.1%, HDFC LARGE AND MID CAP FUND 3.04%, AVEES TRADING AND FINANCE PVT LTD 2%, SBI CONSUMPTION OPPORTUNITIES FUND 1.89%, FRANKLIN INDIA DIVIDEND YIELD FUND 1.84%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202654.84%16.2%7.87%27.01%45.16%
Mar 202654.84%16.4%8.58%26.92%45.16%
Dec 202554.84%11.6%9.03%26.73%45.16%
Sep 202554.84%10%10.93%25.01%45.16%
Jun 202554.84%10.5%11.89%24.06%45.16%
Mar 202554.84%13.4%12.11%23.67%45.16%
Dec 202454.84%9.2%14.11%21.7%45.16%
Sep 202454.84%8.2%14.38%21.51%45.16%